Anemia of Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Anemia of Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: Low Sirtuin-1 Levels Are Linked to Erythropoietin Resistance in Hemodialysis Patients.
A completed clinical trial found that low Sirtuin-1 levels are linked to erythropoietin resistance in patients undergoing hemodialysis.
-
CLINICAL_TRIALS research · 2025-02-17Clinical Trial Update: Iron Isomaltoside for the Treatment of Anemia in Peritoneal Dialysis Patients [Phase 4]
Phase 4 clinical trial evaluating iron isomaltoside for treating anemia in patients undergoing peritoneal dialysis; the study is currently n…
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study) [Phase 4]
Post-marketing Phase 4 real-world evidence study to evaluate the safety of Desidustat for treating anemia in chronic kidney disease patients…
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis Subjects [Phase 3]
Phase 3 study evaluating dose conversion from Mircera to three times weekly oral Vadadustat for maintenance treatment of anemia in hemodialy…
-
CLINICAL_TRIALS trial_result · 2024-12-06Clinical Trial Update: Efficacy and Safety Study of SAL-0951 in the Treatment of Renal Anemia in Patients Receiving Peritoneal Dialysis [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of SAL-0951 for renal anemia in patients receiving peritoneal dialysis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Long Term Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With Anemia Converted From Erythropoieses Stimulating Agent (ESA) Treatment [Phase 3]
This document reports the completion of a Phase 3 long-term trial of intermittent oral ASP1517 in hemodialysis patients with anemia due to c…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: A Study to Investigate the Effect of ASP1517 After Intermittent Oral Dosing in Dialysis Chronic Kidney Disease Patients With Anemia Compared With Darbepoetin as a Reference Drug [Phase 2]
This update summarizes the completion of a Phase 2 trial evaluating ASP1517 versus darbepoetin in dialysis-dependent chronic kidney disease …
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: ASP1517 Phase 2 Clinical Trial - Double-Blind Study of ASP1517 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis- [Phase 2]
This document reports the completion status of a Phase 2 double-blind study evaluating ASP1517 for the treatment of anemia in patients with …
-
CLINICAL_TRIALS trial_result · 2024-08-19Clinical Trial Update: Comparative Study of Two Recombinant Human Erythropoietin Products in Chronic Kidney Disease Patients [Phase 3]
A Phase 3 clinical trial is comparing two recombinant human erythropoietin products in patients with anemia of chronic kidney disease; the s…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Oral Liposomal Iron Versus Injectable Iron Sucrose for Anemia Treatment in Non-Dialysis Chronic Kidney Disease Patients [Phase 4]
Phase 4 trial comparing oral liposomal iron with injectable iron sucrose for anemia in non-dialysis chronic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-13Clinical Trial Update: SAL-0951 Tablets in the Treatment of Renal Anemia in Non-dialysis Chronic Kidney Disease [Phase 3]
This is a Phase 3 trial update showing completion of SAL-0951 tablets for renal anemia in non-dialysis chronic kidney disease. The trial sta…
-
CLINICAL_TRIALS trial_result · 2024-06-28Clinical Trial Update: A Study of AND017 to Treat Anemia in Chronic Kidney Disease Patients on Dialysis [Phase 2]
A Phase 2 clinical trial evaluating AND017 for treating anemia in chronic kidney disease patients on dialysis has completed.
-
CLINICAL_TRIALS trial_result · 2024-06-24Clinical Trial Update: A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis [Phase 3]
A Phase 3 trial evaluating Efepoetin Alfa for anemia in patients with chronic kidney disease on dialysis is currently recruiting. The sponso…
-
CLINICAL_TRIALS research · 2024-06-17Clinical Trial Update: Clinical Validation of the Management Process for Renal Anemia in Maintenance Hemodialysis Patients [NA]
This study is currently recruiting to validate a management approach for renal anemia in adults with chronic kidney disease undergoing maint…
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: Investigation of the Effects of Medium Cut-off Dialyzers Versus High-Flux Dialyzers on Clinical and Laboratory Parameters of Prevalent Hemodialysis Patients
This completed study compares medium cut-off dialyzers to high-flux dialyzers in prevalent hemodialysis patients. It assesses effects on cli…
-
CLINICAL_TRIALS trial_result · 2024-04-22Clinical Trial Update: A Study to Investigate the Effect of Roxadustat Versus Recombinant Human Erythropoietin (rHuEPO) on Oral Iron Absorption in Chinese Patients With Anemia of Chronic Kidney Disease (CKD) [Phase 4]
Phase 4 trial comparing Roxadustat to recombinant human Erythropoietin and its effect on oral iron absorption in Chinese patients with anemi…
-
CLINICAL_TRIALS trial_result · 2023-06-12Clinical Trial Update: Effect of Adding Lactoferrin on Oral Iron on Anemia in Chronic Kidney Disease Patients [Phase 4]
A Phase 4 clinical trial evaluating whether adding lactoferrin to oral iron improves anemia in patients with chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: Study of Roxadustat Conversion in Participants Receiving Stable ESA or as Initial Anemia Treatment in Hemodialysis Participants [Phase 3]
Phase 3 trial evaluating conversion to roxadustat in hemodialysis patients already on stable ESA or as initial anemia treatment; completed w…
-
CLINICAL_TRIALS trial_result · 2021-07-13Clinical Trial Update: Comparison of Darbepoetin Alpha and Recombinant Human Erythropoietin for Treatment of Anemia in Children With Chronic Kidney Disease [Phase 4]
A Phase 4 trial comparing darbepoetin alfa with recombinant human erythropoietin for treating anemia in children with chronic kidney disease…
-
CLINICAL_TRIALS trial_result · 2021-07-06Clinical Trial Update: Efficacy and Safety Study to Evaluate MT-6548 in Peritoneal Dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan [Phase 3]
Phase 3 trial evaluating MT-6548 for anemia in chronic kidney disease patients on peritoneal dialysis in Japan has completed and posted effi…
-
CLINICAL_TRIALS trial_result · 2021-04-13Clinical Trial Update: Iron Dosing Pilot Study Using Model Predictive Control [Phase 4]
A Phase 4 clinical trial evaluating iron dosing using model predictive control in patients with chronic kidney disease-related anemia has co…
-
CLINICAL_TRIALS trial_result · 2021-03-29Clinical Trial Update: Roxadustat in the Treatment of Anemia in Chronic Kidney Disease (CKD) Patients, Not on Dialysis, in Comparison to Darbepoetin Alfa [Phase 3]
Phase 3 trial comparing roxadustat to darbepoetin alfa for treating anemia in non-dialysis chronic kidney disease patients; results have bee…
-
CLINICAL_TRIALS trial_result · 2021-03-22Clinical Trial Update: A Study to Evaluate Efficacy and Safety of JTZ-951 Compared to Darbepoetin Alfa in Korean Renal Anemia Patients Receiving Hemodialysis. [Phase 3]
A Phase 3 trial comparing JTZ-951 to darbepoetin alfa in Korean patients with renal anemia on hemodialysis has completed.
-
FDA approval · 2020-12-02FDA Approved: FERRLECIT — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for Ferrlecit (sodium ferric gluconate complex) submitted by Sanofi-Aventis U.S. LLC, updating t…
-
CLINICAL_TRIALS trial_result · 2020-09-11Clinical Trial Update: Comparison Study of Two Iron Compounds for Treatment of Anemia in Hemodialysis Patients [Phase 4]
Phase 4 trial comparing two iron compounds for treating anemia in hemodialysis patients.